UNSPSC 85503037: Insertion of infusion device into left temporal artery, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to insertion of infusion device into left temporal artery, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03HT33Z

UNSPSC 85503037 Insertion of infusion device into left temporal artery, percutaneous approach is a Commodity code with minimal recent state and local procurement activity aligned to its nominal medical-procedure scope. The recent opportunities tagged to this code span occupational medical surveillance, independent medical evaluation services for pension disability determinations, surgical benefit management, pharmacy administration, temporary health professional staffing, and emergency care for detained youth — none of which involve insertion of infusion devices into temporal arteries or the interventional cardiology and neurology procedures the code nominally describes. The mismatch suggests tagging inconsistency in the state and local procurement systems rather than genuine market activity under the code as written.

Across the six records posted between July and September 2026, issuing bodies include state transportation agencies (Washington State Department of Transportation), county health systems (Santa Clara County Health System), county government (Collier County Board of County Commissioners, Harris County Juvenile Probation Department), and municipal retirement offices (City of Phoenix). The Washington State Ferries medical surveillance RFP (RFP20260825), due October 9, 2026, requires occupational medicine examinations across 14 ferry system locations; the Phoenix Retirement Office independent medical evaluation RFP (RTMRFP26001), due October 16, 2026, seeks disability benefit medical record summaries and physician coordination for approximately 75 annual applications at a maximum contract value of $750,000 over five years. No clear geographic concentration emerges — activity is distributed across Arizona, California, Florida, Texas, and Washington, with no jurisdiction appearing more than once. The code shows no decision-relevant recent activity for firms pursuing infusion-device insertion services.